World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
92
Citations
57305
World Ranking
987
National Ranking
538

Medicine

D-Index
92
Citations
57324
World Ranking
11064
National Ranking
5692

Catherine J. Wu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Catherine J. Wu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 388 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Catherine J. Wu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Catherine J. Wu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Catherine J. Wu is affiliated with Harvard University in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with a focus on oncology, immunology, molecular biology, genetics, and hematology.

The researcher has contributed extensively to topics including CAR-T cell therapy research, cancer immunotherapy and biomarkers, chronic lymphocytic leukemia research, cancer genomics and diagnostics, immune cell function and interaction, single-cell and spatial transcriptomics, and immunotherapy and immune responses.

Some of the recent papers by Catherine J. Wu include:

  • Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma, 2020, Nature Medicine
  • A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors, 2020, Nature Medicine
  • Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns, 2020, Nature Communications
  • Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma, 2021, Nature
  • Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma, 2021, Nature Medicine

They frequently collaborate with researchers including Donna Neuberg, Kenneth J. Livak, Robert J. Soiffer, Jerome Ritz, and Gad Getz, reflecting a broad network within their specialized fields.

The venues that commonly publish their work are:

  • Blood
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood Advances
  • Journal of Clinical Oncology

Best Publications

  • Mutational heterogeneity in cancer and the search for new cancer-associated genes

    Michael S. Lawrence;Petar Stojanov;Petar Stojanov;Paz Polak;Paz Polak;Paz Polak;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov

  • Molecular and genetic properties of tumors associated with local immune cytolytic activity.

    Michael S. Rooney;Sachet A. Shukla;Catherine J. Wu;Gad Getz

  • Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

    Nicholas McGranahan;Nicholas McGranahan;Andrew J. S. Furness;Rachel Rosenthal;Sofie Ramskov

  • Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

    Eliezer M. Van Allen;Eliezer M. Van Allen;Diana Miao;Diana Miao;Bastian Schilling;Sachet A. Shukla;Sachet A. Shukla

  • An immunogenic personal neoantigen vaccine for patients with melanoma

    Patrick A. Ott;Zhuting Hu;Derin B. Keskin;Derin B. Keskin;Sachet A. Shukla;Sachet A. Shukla

  • Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

    A. Gordon Robertson;Jaegil Kim;Hikmat Al-Ahmadie;Joaquim Bellmunt

  • Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia

    Dan A. Landau;Scott L. Carter;Petar Stojanov;Petar Stojanov;Aaron McKenna

  • Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

    Derin B. Keskin;Annabelle J. Anandappa;Jing Sun;Itay Tirosh

  • SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia

    Lili Wang;Michael S. Lawrence;Youzhong Wan;Petar Stojanov

  • Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

    Joshua D Campbell;Anton Alexandrov;Jaegil Kim;Jeremiah Wala

  • Towards personalized, tumour-specific, therapeutic vaccines for cancer

    Zhuting Hu;Patrick A. Ott;Patrick A. Ott;Catherine J. Wu

  • Mutations driving CLL and their evolution in progression and relapse.

    Dan A. Landau;Eugen Tausch;Amaro N. Taylor-Weiner;Chip Stewart

  • Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

    Marios Giannakis;Marios Giannakis;Marios Giannakis;Xinmeng Jasmine Mu;Xinmeng Jasmine Mu;Xinmeng Jasmine Mu;Sachet A. Shukla;Sachet A. Shukla;Zhi Rong Qian

  • Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

    David A. Braun;David A. Braun;Yue Hou;Ziad Bakouny;Miriam Ficial;Miriam Ficial

  • A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors

    Michal Slyper;Caroline B. M. Porter;Orr Ashenberg;Julia Waldman

  • Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

    Sachet A Shukla;Sachet A Shukla;Sachet A Shukla;Michael S Rooney;Michael S Rooney;Mohini Rajasagi;Grace Tiao

  • Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.

    Kyle C. Strickland;Brooke E Howitt;Sachet A Shukla;Scott J. Rodig

  • Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

    Brooke Elizabeth Howitt;Sachet Shukla;Lynette Marie Sholl;Lauren Lee Ritterhouse

  • Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction.

    Jennifer G. Abelin;Derin B. Keskin;Siranush Sarkizova;Christina R. Hartigan

  • Chronic lymphocytic leukaemia.

    Thomas J. Kipps;Freda K. Stevenson;Catherine J. Wu;Carlo M. Croce

  • Ipilimumab for Patients with Relapse after Allogeneic Transplantation

    Matthew S. Davids;Haesook T. Kim;Pavan Bachireddy;Caitlin Costello

Frequent Co-Authors

Donna Neuberg
Donna Neuberg Harvard University
Jerome Ritz
Jerome Ritz Harvard University
Gad Getz
Gad Getz Broad Institute
Sachet A. Shukla
Sachet A. Shukla The University of Texas MD Anderson Cancer Center
Nir Hacohen
Nir Hacohen Harvard University
Robert J. Soiffer
Robert J. Soiffer Harvard University
Jennifer R. Brown
Jennifer R. Brown Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
Eric S. Lander
Eric S. Lander Broad Institute
Joseph H. Antin
Joseph H. Antin Dana-Farber Cancer Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced nursing degrees can open numerous career doors, especially in research, clinical practice, and healthcare management. Many professionals seek affordable education options, which makes exploring cheap psych np programs a practical step for specialization without excessive financial burden.

Salary potential varies widely depending on your specialization and state of employment. Understanding the dnp salary by specialty can help future Immunology professionals plan their careers and investments in education carefully.

Nurses looking to expand their practice from family care to more critical settings should consider additional certifications. For example, pathways like acute care certification for fnp offer focused training for managing complex cases, aligning well with Immunology's clinical demands.

Additionally, accelerated educational paths are highly sought after by those wishing to enter the field quickly. High-quality accelerated np programs allow students to fast-track their nursing credentials without compromising rigor, ideal for Immunology practitioners eager to make an impact.

Best Scientists Citing Catherine J. Wu

Trending Scientists

Recently Published Articles